CEO & Director Of GRAIL Sold 31% Of Their Shares
Earnings Preview: Grail to Report Financial Results Post-market on May 13
SEC to Drop Investigation of Illumina's Grail Deal, Endpoints News Says
Grail Insider Sold Shares Worth $1,635,867, According to a Recent SEC Filing
Grail(GRAL.US) Officer Sells US$3.19 Million in Common Stock
Why GRAIL, Inc. (GRAL) Is Surging in 2025
GRAIL to Announce First Quarter 2025 Financial Results
A Great Week for Institutional Investors Who Own 57% of GRAIL, Inc. (NASDAQ:GRAL)
New Analyst Forecast: $GRAL Given $32.0 Price Target
GRAIL to Present New Data on Galleri and Its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
CCORF Initiates Grail(GRAL.US) With Buy Rating, Announces Target Price $32
This Cancer Test Could Become Routine -- and a Big Seller, Says Analyst -- Barrons.com
Express News | Canaccord Genuity Initiates Coverage On GRAIL With Buy Rating, Announces Price Target of $32
Canaccord Starts Grail With a Buy, Sees 'Solid Upside'
Grail Initiated With a Buy at Canaccord
GRAIL, Inc. (GRAL): A Bull Case Theory
This Family Spent Years Chasing the Holy Grail of a 100% Roth Retirement Portfolio -- WSJ
Jim Cramer Asks Trump To Take Stock As Markets Swing Again Ahead Of 'Liberation Day'
Longevity Medical Institute Integrates OncoSeek to Launch One of Mexico's Most Advanced Cancer Screening Programs